[go: up one dir, main page]

KR970705631A - Weight modulators for nucleic acids and fats, and diagnostics and their therapeutic use - Google Patents

Weight modulators for nucleic acids and fats, and diagnostics and their therapeutic use

Info

Publication number
KR970705631A
KR970705631A KR1019970701038A KR19970701038A KR970705631A KR 970705631 A KR970705631 A KR 970705631A KR 1019970701038 A KR1019970701038 A KR 1019970701038A KR 19970701038 A KR19970701038 A KR 19970701038A KR 970705631 A KR970705631 A KR 970705631A
Authority
KR
South Korea
Prior art keywords
diagnostics
fats
nucleic acids
therapeutic use
weight modulators
Prior art date
Application number
KR1019970701038A
Other languages
Korean (ko)
Other versions
KR100584177B1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/292,345 external-priority patent/US6001968A/en
Priority claimed from US08/438,431 external-priority patent/US6429290B1/en
Priority claimed from US08/483,211 external-priority patent/US6309853B1/en
Application filed filed Critical
Publication of KR970705631A publication Critical patent/KR970705631A/en
Application granted granted Critical
Publication of KR100584177B1 publication Critical patent/KR100584177B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/5759Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1019970701038A 1994-08-17 1995-08-17 Weight modulators, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof Expired - Lifetime KR100584177B1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US08/292,345 US6001968A (en) 1994-08-17 1994-08-17 OB polypeptides, modified forms and compositions
US08/292,345 1994-08-17
US08/347,563 US5935810A (en) 1994-08-17 1994-11-30 Mammalian ob polypeptides capable of modulating body weight, corresponding nucleic acids, and diagnostic and therapeutic uses thereof
US08/438,431 US6429290B1 (en) 1994-08-17 1995-05-10 OB polypeptides, modified forms and derivatives
US08/438,431 1995-06-07
US08/483,211 US6309853B1 (en) 1994-08-17 1995-06-07 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US08/483,211 1995-06-07
US08/347,563 1995-06-07
PCT/US1995/010479 WO1996005309A2 (en) 1994-08-17 1995-08-17 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
KR970705631A true KR970705631A (en) 1997-10-09
KR100584177B1 KR100584177B1 (en) 2006-10-24

Family

ID=46507740

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970701038A Expired - Lifetime KR100584177B1 (en) 1994-08-17 1995-08-17 Weight modulators, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof

Country Status (5)

Country Link
KR (1) KR100584177B1 (en)
BR (1) BRPI9508596B1 (en)
PE (1) PE47396A1 (en)
RS (1) RS50274B (en)
UA (1) UA70911C2 (en)

Also Published As

Publication number Publication date
YU54995A (en) 1998-05-15
PE47396A1 (en) 1996-12-02
BRPI9508596B1 (en) 2018-11-27
RS50274B (en) 2009-07-15
KR100584177B1 (en) 2006-10-24
UA70911C2 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
GR970300021T1 (en) Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
FR2769510B1 (en) HUMAN BODY REBALANCING APPARATUS
DE69623628D1 (en) VIRTUAL MEDICAL INSTRUMENT FOR MEDICAL DIAGNOSTIC TESTING OF PATIENTS
DE69529307D1 (en) Ultrasound diagnosis and treatment system
NZ227177A (en) Vectors and dna compounds for the expression of human protein c
DE69535509D1 (en) Medical diagnostic imaging system and procedure
FI973089A0 (en) Human interleukin-1 receptor helper protein
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
FR2766192B1 (en) EPITOPES OF RSV AND ANTIBODIES COMPRISING SAME, USEFUL IN DIAGNOSIS AND THERAPY
HK1043937A1 (en) Human therapeutic uses of bpi protein products
EP0831793A4 (en) Protein particles for therapeutic and diagnostic use
EP0888381A4 (en) THERAPEUTIC OR DIAGNOSTIC TARGET AGENTS AND METHODS OF PREPARING AND USING THE SAME
PL309386A1 (en) Ortho-amino-substituted benzoyl guanidines, method of obtaining them their application as therapeutric or diagnostic agents and therapeutic agent containing them
ATE109983T1 (en) GEL BODY AND METHODS FOR BIOLOGICAL STERILIZATION CONTROL.
PT928197E (en) USE OF PROTEINS AS AGENTS AGAINST DISEASES OF AUTOIMUNITY NATURE
DE69034218D1 (en) Vaccine and diagnostic for the swine cholera virus
KR970705631A (en) Weight modulators for nucleic acids and fats, and diagnostics and their therapeutic use
AU3698595A (en) Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
AU3329895A (en) Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
AU5103096A (en) Use of ferrites for determining the perfusion of human tissue by m.r. diagnosis
AU738966C (en) Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
TJ425B (en) Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
ITMI940414A0 (en) PROCEDURE FOR THE CONJUGATION OF PROTEINS OF THERAPEUTIC OR DIAGNOSTIC INTEREST
UA25443A (en) METHOD OF EXAMINATION OF VITALITY OF THE SMALL INTESTINE
FR2742766B1 (en) NUCLEOTIDE SEQUENCES, PROTEINS, DRUGS AND DIAGNOSTIC AGENTS USEFUL IN THE TREATMENT OF CANCER

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19970217

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20000814

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20030227

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20040511

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20030227

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20040811

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20040511

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20060228

Appeal identifier: 2004101003521

Request date: 20040811

AMND Amendment
B90T Transfer of trial file for re-examination
PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20040908

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20040811

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20031111

Patent event code: PB09011R02I

PB0901 Examination by re-examination before a trial

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event date: 20040922

Patent event code: PB09012E01I

Comment text: Amendment to Specification, etc.

Patent event date: 20040908

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20040811

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20031111

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20040811

Effective date: 20060228

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20060302

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20040811

Decision date: 20060228

Appeal identifier: 2004101003521

PS0901 Examination by remand of revocation
S901 Examination by remand of revocation
GRNO Decision to grant (after opposition)
PS0701 Decision of registration after remand of revocation

Patent event date: 20060316

Patent event code: PS07012S01D

Comment text: Decision to Grant Registration

Patent event date: 20060303

Patent event code: PS07011S01I

Comment text: Notice of Trial Decision (Remand of Revocation)

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20060522

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20060523

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
G170 Re-publication after modification of scope of protection [patent]
PG1701 Publication of correction

Publication date: 20070703

PR1001 Payment of annual fee

Payment date: 20090518

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20100512

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20110519

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20120503

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20130502

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20130502

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20140519

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20140519

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20150520

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20150520

Start annual number: 10

End annual number: 10

EXPY Expiration of term
PC1801 Expiration of term